Vitrakvi Interactions
There are 515 drugs known to interact with Vitrakvi (larotrectinib), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 67 are major, 427 are moderate, and 21 are minor.
- View all 515 medications that may interact with Vitrakvi
- View Vitrakvi alcohol/food interactions (1)
- View Vitrakvi disease interactions (1)
Most frequently checked interactions
View interaction reports for Vitrakvi (larotrectinib) and the medicines listed below.
- acetaminophen / chlorpheniramine / phenylephrine
- acetazolamide
- Actimmune (interferon gamma-1b)
- aspirin
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Cymbalta (duloxetine)
- Erivedge (vismodegib)
- Gamifant (emapalumab)
- gemfibrozil
- Humira (adalimumab)
- Imbruvica (ibrutinib)
- Luxturna (voretigene neparvovec ophthalmic)
- Nubeqa (darolutamide)
- Ocrevus (ocrelizumab)
- Onpattro (patisiran)
- Otezla (apremilast)
- pyrazinamide
- Rybelsus (semaglutide)
- Savella (milnacipran)
- Sensipar (cinacalcet)
- Spinraza (nusinersen)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tibsovo (ivosidenib)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tremfya (guselkumab)
- Trikafta (elexacaftor / ivacaftor / tezacaftor)
- Vyndaqel (tafamidis)
- Xanax (alprazolam)
- Xgeva (denosumab)
Vitrakvi alcohol/food interactions
There is 1 alcohol/food interaction with Vitrakvi (larotrectinib).
Vitrakvi disease interactions
There is 1 disease interaction with Vitrakvi (larotrectinib) which include:
Report options
QR code containing a link to this page
More about Vitrakvi (larotrectinib)
- Vitrakvi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
